STOCK TITAN

Xtant Medical Holdings Inc - XTNT STOCK NEWS

Welcome to our dedicated news page for Xtant Medical Holdings (Ticker: XTNT), a resource for investors and traders seeking the latest updates and insights on Xtant Medical Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Xtant Medical Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Xtant Medical Holdings's position in the market.

Rhea-AI Summary
Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its financial results for Q4 and full year 2023 on April 1, 2024. The conference call hosted by the President and CFO will discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
earnings
-
Rhea-AI Summary
Xtant Medical Holdings, Inc. amends credit agreement with MidCap Financial Trust, increasing commitment to $17.0 million and term loan by $10.0 million. Maturity dates extended to 2029, revenue requirements reset, EBITDA requirements removed, and interest rate margin reduced to 6.50%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.51%
Tags
none
-
Rhea-AI Summary
Xtant Medical Holdings, Inc. (XTNT) CEO to present at TD Cowen 44th Annual Healthcare Conference. The presentation will be on March 4, 2024, at 12:50 p.m. ET in Boston. A live webcast will be accessible on the Company’s website. A replay will be available for 90 days post-presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.31%
Tags
conferences
Rhea-AI Summary
Xtant Medical Holdings, Inc. (XTNT) will participate in two upcoming investor conferences: Canaccord Genuity 2024 Musculoskeletal Conference and BTIG Medtech, Digital Health, Life Science and Diagnostic Tools Conference. President and CEO, Sean Browne, and CFO, Scott Neils, will present and participate in 1x1 meetings with institutional investors. The live webcast of the Canaccord presentation will be available on the Company's website, with a replay following the conclusion of the presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
conferences
-
Rhea-AI Summary
Xtant Medical Holdings, Inc. (NYSE American: XTNT) announces participation in Jefferies London Healthcare Conference and 14th Annual Craig-Hallum Alpha Select Conference. President and CEO, Sean Browne, to present at Jefferies conference. Live webcast available on company website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
conferences
-
Rhea-AI Summary
Xtant Medical Holdings, Inc. (XTNT) raises 2023 Annual Revenue Guidance to $88 Million - $91 Million, reports record third quarter revenue of $25 million, an 18% organic growth, and a 73% year-over-year increase. Gross margin for Q3 2023 was 61.3% and net income totaled $9.2 million. The company also plans to host a conference call to discuss the financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
none
Rhea-AI Summary
Xtant Medical Holdings, Inc. will release its financial results for Q3 2023 on November 9, 2023. The company is a global medical technology company focused on surgical solutions for spinal disorders. President and CEO Sean Browne, and CFO Scott Neils, will host a conference call at 9:00 AM ET on the same day to review the results. The conference call details are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
earnings
-
Rhea-AI Summary
Xtant Medical Holdings, Inc. has acquired the nanOss production operations from RTI Surgical, Inc. for $2 million in cash plus contingent payments. The acquisition includes assets and inventory used in RTI's synthetic bone graft business and the lease for the nanOss production facility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
acquisition
-
Rhea-AI Summary
Xtant Medical Holdings to exhibit orthobiologics and spinal fixation products at NASS 2023 Annual Meeting
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
none
Rhea-AI Summary
Xtant Medical Holdings has completed the acquisition of certain assets and liabilities related to the biologics and spinal fixation offerings of Surgalign Holdings. The all-cash transaction was worth $5 million, plus assumed liabilities. Xtant Medical aims to integrate this business with its current offerings to maximize its potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
acquisition
Xtant Medical Holdings Inc

NYSE:XTNT

XTNT Rankings

XTNT Stock Data

152.23M
39.64M
7.19%
69.33%
0.15%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Belgrade

About XTNT

xtant medical (nyse mkt: xtnt) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. with core competencies in both biologic and non-biologic surgical technologies, xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. for further information, please visit xtantmedical.com.